Food Allergy Research & Education (FARE) has introduced a series of new and updated resources aimed at supporting individuals affected by food allergies in the United States. The announcement was made during the 2026 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting, which is taking place in Philadelphia from February 27 to March 2.
Among the resources unveiled is the National Indicator Report on Food Allergy, developed with support from the Centers for Disease Control and Prevention through the Food Allergy AWARE initiative. This report establishes a baseline for understanding the current state of food allergy across the country. The report can be accessed and downloaded online.
FARE also launched “Anatool,” a clinical support tool designed to help healthcare professionals identify anaphylaxis. Developed in collaboration with Dr. Timothy E. Dribin of Cincinnati Children’s Hospital, Anatool is based on international consensus guidelines published in 2024 and is intended solely for use by medical professionals.
In partnership with Carebox, FARE has updated its Food Allergy Clinical Trial Finder tool. The enhancements aim to simplify the process for patients seeking eligible clinical studies, which could help accelerate recruitment for trials focused on new diagnostics and therapies.
A new resource created with the Alpha-gal Alliance addresses misconceptions about Alpha-gal Syndrome, aiming to move public understanding beyond simply labeling it as a “red meat allergy.” More information about this resource is available online.
Additionally, FARE collaborated with Arkansas Children’s Hospital allergists to present research on its Neighborhoods Initiative program in Central Arkansas and Newark, New Jersey. The program provided food-insecure households with access to allergen-safe foods and virtual education over several months. According to research led by Dr. Nadia Makkoukdji and colleagues Marie Malloy, Elizabeth Bradford (of FARE), and Dr. Amy M. Scurlock (Arkansas Children’s Hospital), participants experienced improved quality of life, reduced financial stress, and increased confidence in managing food allergies.
“Food allergy is a serious disease of the immune system affecting more than 1 in 10 Americans, yet it has been chronically under-resourced relative to its public health impact,” said Sung Poblete, PhD, RN, CEO of FARE. “The release of these new resources reflects FARE’s commitment not only to giving clinicians, researchers and public health professionals the tools they need to improve the quality of life and health of those managing food allergy, but also to elevating public awareness of this top-tier public health issue. We are pleased to announce these new resources, which will further support the food allergy community.”
FARE is exhibiting at booth 1515 during the AAAAI conference. Additional details can be found at www.foodallergy.org.
